Avadel Pharmaceuticals PLC Sustainability Reports
Avadel Pharmaceuticals plc is a biopharmaceutical company focused on the development and commercialization of medications. Its primary product is LUMRYZ, an FDA-approved once-at-bedtime extended-release oral suspension formulation of sodium oxybate for treating narcolepsy patients.
Sector: Manufacturing
Country: Ireland
Exchange: Nasdaq
ISIN: US05337M1045
6 reports from 2016 to 2024